Blood Screening Market by Product (Instrument, Reagent & Kits, Software), Technology (Nucleic Acid Amplification, ELISA, Rapid Test, Western Blot), End User (Blood Bank, Hospital) – 2020 to 2025

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: March 23, 2020
Clear
SKU: GMS-2064 Category:

The blood screening market is expected to reach USD 4.23 billion by 2025, rising over the forecast period at a CAGR of 8.32%. The growing demand for donated blood, the increasing number of blood donations, the increasing prevalence of infectious diseases, and the increasing prevalence of new pathogens are driving this market’s growth.

Blood Screening Market by Product (Instrument, Reagent & Kits, Software), Technology (Nucleic Acid Amplification, ELISA, Rapid Test, Western Blot), End User (Blood Bank, Hospital) - 2020 to 2025 1

Blood Screening Market by Product (Instrument, Reagent & Kits, Software), Technology (Nucleic Acid Amplification, ELISA, Rapid Test, Western Blot), End User (Blood Bank, Hospital) - 2020 to 2025 2

Blood Screening Market by Product (Instrument, Reagent & Kits, Software), Technology (Nucleic Acid Amplification, ELISA, Rapid Test, Western Blot), End User (Blood Bank, Hospital) - 2020 to 2025 3

Blood Screening Market by Product (Instrument, Reagent & Kits, Software), Technology (Nucleic Acid Amplification, ELISA, Rapid Test, Western Blot), End User (Blood Bank, Hospital) - 2020 to 2025 4

Blood Screening Market by Product (Instrument, Reagent & Kits, Software), Technology (Nucleic Acid Amplification, ELISA, Rapid Test, Western Blot), End User (Blood Bank, Hospital) - 2020 to 2025 5

Blood Screening Market by Product (Instrument, Reagent & Kits, Software), Technology (Nucleic Acid Amplification, ELISA, Rapid Test, Western Blot), End User (Blood Bank, Hospital) - 2020 to 2025 6

Blood Screening Market by Product (Instrument, Reagent & Kits, Software), Technology (Nucleic Acid Amplification, ELISA, Rapid Test, Western Blot), End User (Blood Bank, Hospital) - 2020 to 2025 7

Blood Screening Market by Product (Instrument, Reagent & Kits, Software), Technology (Nucleic Acid Amplification, ELISA, Rapid Test, Western Blot), End User (Blood Bank, Hospital) - 2020 to 2025 8

1 Global Blood Screening Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Blood Screening Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Blood Screening Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Blood Screening Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Blood Screening Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Blood Screening Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Blood Screening Market – By Product Type (Market Size – & million/billion)
8.1 Reagents and Kits
8.2 NAT Reagents and Kits
8.3 ELISA Reagents and Kits
8.4 Others

9 Global Blood Screening Market – By Technology
9.1 Transcription-Mediated Amplification
9.2 Real-time Polymerase Chain Reaction
9.3 Fluorescent immunoassay
9.4 Rapid Tests
9.5 Western Blot Assays
9.6 Other

10 Global Blood Screening Market – By End-User
10.1 Blood Banks
10.2 Hospitals

11 Global Blood Screening Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Blood Screening Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Blood Screening Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 F. Hoffmann-La Roche
13.3 GE Healthcare
13.4 Becton, Dickson and Company
13.5 Bio-Rad Laboratories
13.6 Danaher Corporation
13.7 Abbott Laboratories
13.8 Ortho Clinical Diagnostics
13.9 Thermo Fisher Scientific
13.10 Siemens Healthineers
13.11 Biomérieux
13.12 Company 11 & more

14 Global Blood Screening Market – Appendix
14.1 Sources
14.2 Abbreviations